GEMMABio focuses on creating new innovative medicines accessible to all, especially for patients with rare diseases, as soon as possible. Franklin Biolabs is owned and operated by Dr. Jim Wilson, the gene therapy researcher who also helms the Sheik’s investment firm.

GEMMABio continues to pursue strategic alliances to support the objectives of revolutionizing patient-centered care across the globe.